All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @cgo_of_me on TikTok · 151s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @cgo_of_me's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Welcome to Frustrated Friday. We're going to talk about two of the biggest things I've
  2. 0:02been hearing from you guys all week long and number one is the scale is not moving. You're
  3. 0:08stuck at a plateau where you've stopped losing weight. Now for reference I've been on a
  4. 0:11zimpicant or manjaro for about a year and a half so I've been through a couple different
  5. 0:16cycles now and I've lost 75 pounds well, 77 as of this morning. I just got off of a three month long
  6. 0:23plateau and it was driving me crazy. The first thing I can tell you guys with this medication is
  7. 0:31you're going to stall out and it's going to happen several times regardless of what you do. These are
  8. 0:37your body's set points. It's your body recalibrating so to speak and that's where your body's getting
  9. 0:44new and adjusting to this new weight. It happens to everybody. It's part of every weight loss journey.
  10. 0:50You can get through it. You don't necessarily have to do anything different. Now what I will tell you
  11. 0:55is there will come a point and I've been seeing a lot of creators at this point recently where you
  12. 1:01hit a big stop and generally it's right around a point where you haven't broken through that weight
  13. 1:07in your adult life or you haven't been that weight in your adult life or you haven't made any changes
  14. 1:15to what you're doing. Because let's be real, a lot of us, especially me too, started this journey by
  15. 1:21not changing anything, relying on the appetite suppression to get us through and then the weight
  16. 1:27started dropping and that's great. But you'll hit that point where you have to make lifestyle changes
  17. 1:32for the weight's not going to drop any further. So what are you doing? You hit that point, you have
  18. 1:36to look at everything and the first thing you need to do is take a week and log everything you're eating
  19. 1:42and everything you're doing and see what that actually looks like. And I know a lot of us don't
  20. 1:47want to track calories but you have to know where you're starting from to know where you're going.
  21. 1:52Next up your water intake. A lot of us started drinking off a lot of water,
  22. 1:58kind of fell off, didn't really get there. Up it, get it as close to a gallon as you can.
  23. 2:04And lastly, lead with protein. And when I say lead with protein, I mean this. You don't have to check
  24. 2:09macros. You don't need to check carbs and fats, most of us do just fine with that.
  25. 2:14Track protein. For a grown adult, you need half a gram of protein per pound of body weight.
  26. 2:20Hit your protein goal, no matter what it takes and the rest is going to fall into place.
  27. 2:25It might take a little bit for that scale to move but remember, you're at a new place in life.

TikTok's Ozempic plateau tips: what the science says

Your Friend Mel

TikTok creator

282.2K viewsWatch on TikTok

Quick answer

Weight loss plateaus are a documented pharmacological and metabolic phenomenon during GLP-1 receptor agonist therapy, observed in pivotal semaglutide and tirzepatide trials where weight stabilization occurs even with continued medication use. The creator's advice to prioritize protein intake and food logging is directionally consistent with obesity medicine guidelines, though the recommended protein target of 0.5 grams per pound of body weight is below the threshold most evidence supports for lean mass preservation during a caloric deficit. Patients experiencing extended plateaus despite medication adherence should consult their prescribing clinician to evaluate whether dose titration or additional behavioral support is warranted.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 11 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TikTok's Ozempic plateau tips: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TikTok's Ozempic plateau tips: what the science says" from Your Friend Mel. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Weight loss plateaus are a documented pharmacological and metabolic phenomenon during GLP-1 receptor agonist therapy, observed in pivotal semaglutide and tirzepatide trials where weight stabilization occurs even with continued medication use.

The reason this review is not generic is the source wording and the canonical claim label "glp1 tips to break through a weightloss plateau on ozempic and mo." In this clip, the useful excerpt is: "Welcome to Frustrated Friday." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The recommended protein target of 0.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Weight loss plateaus are a documented pharmacological and metabolic phenomenon during GLP-1 receptor agonist therapy, observed in pivotal semaglutide and tirzepatide trials where weight stabilization occurs even with continued medication use.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Weight loss plateaus are a documented pharmacological and metabolic phenomenon during GLP-1 receptor agonist therapy, observed in pivotal semaglutide and tirzepatide trials where weight stabilization occurs even with continued medication use. The creator's advice to prioritize protein intake and food logging is directionally consistent with obesity medicine guidelines, though the recommended protein target of 0.5 grams per pound of body weight is below the threshold most evidence supports for lean mass preservation during a caloric deficit. Patients experiencing extended plateaus despite medication adherence should consult their prescribing clinician to evaluate whether dose titration or additional behavioral support is warranted.
  • GLP-1 trial data show weight stabilization typically begins around week 60 of semaglutide treatment, confirming plateaus are expected, not a medication failure (Wilding et al., 2021, NEJM).
  • The recommended protein target of 0.5 grams per pound of body weight is likely insufficient for lean mass preservation during active weight loss; most sports nutrition guidelines support 0.7 to 1 gram per pound in a caloric deficit.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • GLP-1 trial data show weight stabilization typically begins around week 60 of semaglutide treatment, confirming plateaus are expected, not a medication failure (Wilding et al., 2021, NEJM).
  • The recommended protein target of 0.5 grams per pound of body weight is likely insufficient for lean mass preservation during active weight loss; most sports nutrition guidelines support 0.7 to 1 gram per pound in a caloric deficit.
  • Food logging is one of the most evidence-backed behavioral tools for weight loss: Burke et al. (2011) found logging frequency was the single strongest predictor of weight loss in a controlled behavioral study.
  • Metabolic adaptation, not a fixed 'set point,' is the more accurate explanation for GLP-1 plateaus: the body reduces resting energy expenditure in response to sustained caloric restriction.
  • Hydration supports satiety and kidney function during rapid weight loss, but optimal daily intake varies by body size; the general guidance to increase water intake is sound even if the 'gallon a day' target is not universal.
  • Patients on stable GLP-1 doses who experience extended plateaus without weight change should consult their prescriber about dose titration or a clinical review, not rely on social media advice alone.
  • Compounded semaglutide or tirzepatide products are not equivalent to FDA-approved brand-name medications; patients using compounded versions should be especially diligent about clinical follow-up.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @cgo_of_me actually say?

The creator, a self-described year-and-a-half GLP-1 user who says they've lost 77 pounds, gave three pieces of advice for breaking a weight loss plateau on Ozempic or Mounjaro: log your food for a week, increase water intake toward a gallon a day, and hit a protein target of "half a gram of protein per pound of body weight." They also framed plateaus as natural "set points" where the body is "recalibrating" to a new weight, and argued that appetite suppression alone eventually stops working, requiring actual lifestyle changes.

The video is personal experience framed as general advice, which is a meaningful distinction. The creator is not a clinician. But they're also not claiming to be one, which matters when evaluating what they actually said.

Does the science back this up?

Largely, yes, with one notable exception on protein targets. The broader framework here, that GLP-1-assisted weight loss eventually requires behavioral change, is well-supported. The protein recommendation, though, is undershooting what the evidence actually says.

Weight loss plateaus during GLP-1 therapy are real and documented. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed that semaglutide users hit their lowest weight around week 60, after which weight often stabilized even with continued medication. Tirzepatide data from the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) shows a similar curve. The mechanism isn't mysterious: reduced caloric intake triggers metabolic adaptation, including lower resting energy expenditure.

On protein, the 0.5 grams per pound recommendation translates to roughly 0.8 to 1.1 grams per kilogram of body weight. Current evidence, including guidelines from the International Society of Sports Nutrition (Stokes et al., 2018, Journal of the International Society of Sports Nutrition), supports 1.6 to 2.2 grams per kilogram for lean mass preservation during a caloric deficit. For a person actively trying to preserve muscle while losing fat, the creator's target is probably too low.

What did they get wrong (or right)?

They got the general direction right and the specific numbers wrong. Credit where it's due: encouraging food logging, hydration, and protein prioritization during a GLP-1 plateau is reasonable, practical advice. Research on self-monitoring of eating behavior consistently links food logging to better weight loss outcomes (Burke et al., 2011, Journal of the American Dietetic Association).

The "set point" framing is more folklore than science. The body does undergo metabolic adaptation during weight loss, but the classic set point theory, the idea that the body defends a specific weight, is contested. A more accurate framing is adaptive thermogenesis, where metabolic rate drops in response to sustained caloric restriction (Rosenbaum and Leibel, 2010, Science Translational Medicine). Calling it "recalibrating" is close enough for a TikTok audience, but it's not a precise description of what's happening physiologically.

The protein number is the clearest error. "Half a gram per pound" will leave many GLP-1 users under-protected against muscle loss, particularly older adults, where sarcopenia risk is already elevated. The creator should have said closer to 0.7 to 1 gram per pound, which aligns with most sports nutrition and obesity medicine guidelines for individuals in a deficit.

What should you actually know?

Plateaus during GLP-1 therapy are real, expected, and not a sign the medication stopped working. The clinical literature is consistent on this. What breaks them is not magic, it is the same thing that works in any caloric-deficit scenario: understanding your actual intake, protecting lean mass, and not mistaking a stall for failure.

Three things worth knowing:

  • Protein targets matter more on GLP-1s because appetite suppression can lead to significant under-eating, which accelerates muscle loss. Aim closer to 0.7 to 1 gram per pound of body weight, not 0.5, especially if you are over 50 or sedentary.
  • Hydration affects appetite signaling and kidney function during rapid weight loss. A gallon per day is aggressive for smaller individuals but the direction is right. Aim for at least half your body weight in ounces as a baseline.
  • If you have been on a stable dose of semaglutide or tirzepatide for more than six months with no weight change, talk to your prescriber. A dose adjustment or medication review may be appropriate. That is a clinical conversation, not a TikTok one.

The creator's lived experience is real and the advice is mostly harmless. But "mostly harmless" is not the same as "medically optimized."

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Your Friend Mel · TikTok creator

282.2K views on this video

Tips to break through a weightloss plateau on ozempic and mounjaro. Stuck at a weight you are goimg to want to watch this whole video #ozempic #mounjaro #wegovy #weightloss #mounjarotips #frustratedf

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about glp-1 trial data show weight stabilization typically begins around week?

GLP-1 trial data show weight stabilization typically begins around week 60 of semaglutide treatment, confirming plateaus are expected, not a medication failure (Wilding et al., 2021, NEJM).

What does the video say about the recommended protein target of 0.5 grams per pound of?

The recommended protein target of 0.5 grams per pound of body weight is likely insufficient for lean mass preservation during active weight loss; most sports nutrition guidelines support 0.7 to 1 gram per pound in a caloric deficit.

What does the video say about food logging?

Food logging is one of the most evidence-backed behavioral tools for weight loss: Burke et al. (2011) found logging frequency was the single strongest predictor of weight loss in a controlled behavioral study.

What does the video say about metabolic adaptation, not a fixed 'set point,'?

Metabolic adaptation, not a fixed 'set point,' is the more accurate explanation for GLP-1 plateaus: the body reduces resting energy expenditure in response to sustained caloric restriction.

What does the video say about hydration supports satiety?

Hydration supports satiety and kidney function during rapid weight loss, but optimal daily intake varies by body size; the general guidance to increase water intake is sound even if the 'gallon a day' target is not universal.

What does the video say about patients on stable glp-1 doses who experience extended plateaus without?

Patients on stable GLP-1 doses who experience extended plateaus without weight change should consult their prescriber about dose titration or a clinical review, not rely on social media advice alone.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Your Friend Mel, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.